The Rare Blood Therapy Manager (RBTM) must assume responsibility for achieving sales objectives by implementing approved marketing and local sales strategies aimed at effectively selling and promoting NNIs hemophilia products to key physicians, nurses, home care companies, social workers, pharmacies, hemophilia/hematology organizations, and other appropriate paramedical customers who make or are involved in purchasing and prescribing decisions. The Rare Disease portfolio includes medical treatments, customer solutions, and devices across multiple Therapy Areas including Rare Bleeding Disorders, Rare Endocrine Disorders, Rare Renal Disorders, and Hemoglobinopathies (Sickle Cell Disease & Beta Thalassemia), as well as new products in the pipeline.